Beneficial effect of the addition of the 5-HT 2A/2C and alpha 2 antagonistmianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients
A. Grinshpoon et al., Beneficial effect of the addition of the 5-HT 2A/2C and alpha 2 antagonistmianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients, EUR PSYCHIA, 15(6), 2000, pp. 388-390
Atypical neuroleptics that block serotonin 2A (5-HT 2A) and dopamine 2 (D2)
receptors have been shown to possess efficacious antipsychotic activity. W
e assessed the efficacy of the addition of the 5-HT 2A/2C and alpha 2 antag
onist mianserin to ongoing haloperidol treatment in chronically hospitalize
d (>10 years) drug-resistant schizophrenic patients (N = 12). The patients
were assessed at baseline and every three months for one year with the Brie
f Psychiatric Rating Scale and the Clinical Global Impression. Results show
ed a significant (but < 10%) improvement in the core symptoms of schizophre
nia; however, only the reduction (by 43%) in anxiety was clinically relevan
t (P < 0.0001). The beneficial effect of mianserin may be related to the co
mbined blockade of 5-HT 2A and histamine (H1) receptors. (C) 2000 Editions
scientifiques et medicales Elsevier SAS.